USSA-AVAA-TAS 2026 Abstract Submission
  • USSA-AVAA-TAS 2026 Abstract Submission

    If you submitted an abstract to ANESTHESIOLOGY® 2026, a separate submission of your abstract to the USSA/AVAA/TAS annual meeting is explicitly permitted by ASA, USSA, AVAA, and TAS. Fill out one form per submission using the contact information of the author who will receive all correspondence related to the submission acceptance and scheduling. Please use author contact information that will still be effective on October 16, 2026. All forms must be submitted by Sunday, June 28, 2026 (11:59 p.m. CT).
  • Please note that this submission form is specifically for the 2026 USSA/AVAA/TAS Annual Meeting and is not the submission site for ANESTHESIOLOGY® 2026 abstracts.

  • Corresponding Author

  • Format: (000) 000-0000.
  • Is the Corresponding Author the same person as the Presenting Author?*
  • Presenting Author

    If the Presenting Author is not the same person as the Corresponding Officer, please fill out the fields in this section.
  • Format: (000) 000-0000.
  • Please select your abstract type.*
  • 0/800
  • Browse Files
    Drag and drop files here
    Choose a file
    Cancelof
  • Attestations

  • If my abstract is accepted, I (or a co-author) will attend the Academic Meeting on October 16, 2026 in San Diego or a co-author or colleague will attend in my place. In case there is a change in the presenter, I will contact Danielle Ishak at d.ishak@asahq.org as soon as it is known to ensure timely change. I agree.*
  • I understand that I must contact the USSA/AVAA/TAS personnel with any requests to make changes to my submission after the June 28, 2026 deadline. Changes will be reviewed and accepted on a case-by-case basis. Typically, only minor changes, grammatical changes, or changes to authors will be made. I will contact Danielle Ishak at d.ishak@asahq.org with all change requests. DEADLINE FOR ALL CHANGES: Friday, July 3, 2026. I agree.*
  • Should I have a scheduling conflict, I understand that abstracts cannot be rescheduled for a different day/time. A co-author may be appointed as the presenter if the primary author cannot present. I agree.*
  • If the USSA/AVAA/TAS Academic Meeting Abstract Review Committee withdraws my abstract for reasons including, but not limited to, irregularities or misconduct, I understand that I may not submit an abstract for the following year. I agree.*
  • USSA/AVAA/TAS Academic Meeting Policy on Scientific Abstracts: I understand that abstracts submitted for presentation at the USSA/AVAA/TAS Academic Meeting must not have been published prior to October 1, 2026 at any local, national or international meeting* or broadcasted or published, in print or digital format, including journals, newsletters, news media coverage and education products. Internal presentations to small groups within the authors’ institution are permitted. For inquiries regarding news releases on these abstracts, please contact Danielle Ishak at d.ishak@asahq.org. I agree.*
  • I understand that the following USSA/AVAA/TAS 2026 Academic Annual Meeting Scientific Abstract Embargo Policy applies: Embargo policies have been adopted from the ASA annual meeting guidance in that all scientific abstracts accepted for presentation are embargoed (may not be published or publicized) until the date and time of presentation. I agree.*
  • By submitting an abstract on this USSA/AVAA/TAS website, you represent that you own or otherwise have the rights to the written summaries of research or observations ("Abstract") you provided to the USSA/AVAA/TAS on this site. USSA/AVAA/TAS acknowledges and agrees that as between USSA/AVAA/TAS and you, you own all right, title and interest of any nature, throughout the world, in and to the Abstract, including any copyright registration or applications for copyright registrations relating thereto anywhere in the world. You grant to USSA/AVAA/TAS anon-exclusive, perpetual, sub-licensable, worldwide, right and license (or sublicense, as the case may be) to use, copy, modify, reproduce, publicly display, publicly perform, transmit, distribute or otherwise make available the Abstract in any form or format, including without limitation, through the Internet on various websites of USSA/AVAA/TAS and USSA/AVAA/TAS's licensees or USSA/AVAA/TAS's affiliates, intranets, and any other technologies whether now known or developed in the future; and to permit end-users to copy, display and print it for their own personal or business use (but not for resale by any such end-user). I agree.*
  • For Scientific Studies and Medically Challenging Case Reports, please indicate your answer to the following statement: I have satisfied the requirements of my institution or organization regarding the use of human subjects or animals in research and received approval of the Internal Review Board (IRB) or Institutional Animal Care and Use Committee (IACUC) respectively.*
  • I understand that as the corresponding author my email address may be shared with the moderator(s) of the session if my submission is accepted. Moderators may contact presenters prior to the conference regarding their presentation.*
  • Signature Date*
     - -
  • Should be Empty: